A Prospective, Randomized, Controlled, Multi-Center Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft Versus Standard of Care in the Management of Non-Healing Venous Leg Ulcers

Lead Presenter

Supporting Presenters

Dennis P. Orgill, MD, PhD
David Armstrong, DPM, MD, PhD
Robert D. Galiano, MD
Paul Glat, MD
Jarrod Kaufman, MD
Lawrence, A. DiDomenico, DPM
Marissa J Carter, MA, PhD
Charles M. Zelen, DPM

Presented At


Venous leg ulcerations (VLUs) frequently represent a significant clinical challenge. Dehydrated human amnion and chorion allografts have shown great promise in the treatment of recalcitrant VLUs when compared to standard wound care (SOC) alone which includes debridement followed by multilayer compression therapy with a primary ab-sorptive dressing. Adding placental grafts into the treatment regimen is often successful as they are rich in extracel-lular matrix proteins, growth factors, and cytokines, and as such can induce angiogenesis and dermal fibroblast pro-liferation which can lead to accelerated healing. Aseptically processed grafts may have a benefit over those that are terminally sterilized. The goal of this study was to compare aseptically processed dehydrated human amnion and chorion allograft (dHACA) applied weekly or biweekly combined with standard wound care versus standard of care alone in facilitating wound closure in non-healing VLUs. The research was reviewed and approved by the Western Institutional Review Board and registered on ClinicalTrials.gov.

Patients with non healing VLUs treated with SOC (appropriate debridement, primary absorptive dressing and multi-layer compression) after a 2-week screening period were randomized to either receive SOC (20 patients) or wound-size-specific dHACA plus SOC applied weekly (20 patients) or wound-size-specific dHACA plus SOC applied bi-weekly (20 patients) for up to 12 weeks. Primary endpoint of this clinical trial was percent of patients healed and completely epithelialized at 12 weeks.

At study conclusion, both weekly and biweekly application of dHACA was statistically significantly better at healing VLUs then standard wound therapy and at a faster overall rate. In conclusion, aseptically processed dHACA should be considered as a viable option for the refractory venous leg wounds.

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.